Cargando…
Chain Substituted Cannabilactones with Selectivity for the CB2 Cannabinoid Receptor
In earlier work, we reported a novel class of CB2 selective ligands namely cannabilactones. These compounds carry a dimethylheptyl substituent at C3, which is typical for synthetic cannabinoids. In the current study with the focus on the pharmacophoric side chain at C3 we explored the effect of repl...
Autores principales: | Alapafuja, Shakiru O., Nikas, Spyros P., Ho, Thanh C., Tong, Fei, Benchama, Othman, Makriyannis, Alexandros |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804212/ https://www.ncbi.nlm.nih.gov/pubmed/31581433 http://dx.doi.org/10.3390/molecules24193559 |
Ejemplares similares
-
Synthesis of Functionalized Cannabilactones
por: Liu, Yingpeng, et al.
Publicado: (2020) -
Blockade of CB1 or Activation of CB2 Cannabinoid Receptors Is Differentially Efficacious in the Treatment of the Early Pathological Events in Streptozotocin-Induced Diabetic Rats
por: Spyridakos, Dimitris, et al.
Publicado: (2022) -
Expression and Function of Cannabinoid Receptors CB1 and CB2 and Their Cognate Cannabinoid Ligands in Murine Embryonic Stem Cells
por: Jiang, Shuxian, et al.
Publicado: (2007) -
Controlled-Deactivation CB1 Receptor Ligands as a Novel Strategy to Lower Intraocular Pressure
por: Miller, Sally, et al.
Publicado: (2018) -
PM288. Preclinical Evaluation of Neutral Cannabinoid CB1 Receptor Antagonists and Cannabinoid CB1 Receptor Negative Allosteric Modulators for Treating Drug Addiction
por: Gardner, Eliot L., et al.
Publicado: (2016)